MarketsNotableCorroborating
5.4
Citi: Eli Lilly Extends GLP-1 Lead Over Novo in US Market
Dagens IndustriLO·US · DK·about 3 hours ago
Thailand reclassified GLP-1 weight-loss drugs as prescription-only to curb a black-market surge and influencer-driven misuse. The move follows skyrocketing uptake of Ozempic and similar medicines, with counterfeit supply a known problem. Enforcement and impact on illegal supply remain uncertain.